informeddna1

3 Trends that Promise to Quietly Revolutionize Genomics in 2022

As we enter into 2022, health organizations should expect three industry-wide issues that have simmered on the back burner to begin rising to the forefront:  Equitable access to care; Stronger embrace of telehealth technologies; Advances in personalized medicine and how to know when they’re ready (or not) for prime time standard of care. Below is …

3 Trends that Promise to Quietly Revolutionize Genomics in 2022 Read More »

We’re Thankful for Our Genetic Counselors… Here’s Why

Founded in 2007 as the first telehealth genetics services company in the U.S., we offer the largest staff of experienced genetic specialists, providing coverage across all genetics specialties and across all states, with licensure in states that require it. InformedDNA isn’t lab-owned or lab-sponsored, so our counselors have no conflicts of interest in advising ordering …

We’re Thankful for Our Genetic Counselors… Here’s Why Read More »

DEI in healthcare and genomics

Diversity, Equity, Inclusion Crucial to the Future of Healthcare and Genomics

“Health equity cannot be achieved without actual lived experiences informing and advancing policies, regulations, laws, and initiatives that address disability rights, accessibility, and inclusion.”– Dr. Richard Besser, Robert Wood Johnson Foundation In today’s complex healthcare landscape, improving the quality of and access to care goes hand in hand with diversity, equity, and inclusion (DEI) initiatives. …

Diversity, Equity, Inclusion Crucial to the Future of Healthcare and Genomics Read More »

Determining Breast Cancer Risk and Screening Methodologies

Determining Breast Cancer Risk and Screening Methodologies

October is breast cancer awareness month. With roughly 281,500 estimated new diagnoses of breast cancer in the U.S. in 2021, it is important for healthcare providers to be aware of a patient’s risk of developing breast cancer in order to facilitate appropriate cancer screening, surveillance, and referrals to specialists.   After hearing that one in …

Determining Breast Cancer Risk and Screening Methodologies Read More »

Complex Diseases, Small Populations: Overcoming Challenges in Bringing Precision Medicine Therapies to Market

Complex Diseases, Small Populations: Overcoming Challenges in Bringing Precision Medicine Therapies to Market

Genetic testing and precision treatments hold a great deal of promise for millions of patients and families. However, access to these treatments is often limited by geography as well as socioeconomic status. Patients with rare subtypes of common diseases like Alzheimer’s or diseases that are not currently recognized as being linked to genetic mutations face …

Complex Diseases, Small Populations: Overcoming Challenges in Bringing Precision Medicine Therapies to Market Read More »

Case Study Overview: Large Regional Health Plan Enhances Total Market Value

Facing a surge in genetic test options, one large regional health plan’s leadership team wanted a solution that would guarantee its providers and members access to timely guidance and evidence-based testing standards. To maximize total market value, the health plan implemented the full suite of solution capabilities, including: • Robust, evidence-based clinical guidelines • Reviews …

Case Study Overview: Large Regional Health Plan Enhances Total Market Value Read More »

Partner with genetic experts

Partnering with Genetics Experts Helps Accelerate FTD Clinical Trials

Having a partner with genetics expertise throughout the clinical trial and pre-and post-market stages of drug development, especially for rare diseases, is an asset to biotech companies as well as patients. From guiding patients through a remote screening process to providing pre-and post-test genetic counseling about the disease and treatment options, we work hand-in-hand with …

Partnering with Genetics Experts Helps Accelerate FTD Clinical Trials Read More »

Expanded carrier screening

ACMG Carrier Screening Recommendations: Points To Consider For An Effective and Equitable Carrier Screening Program

The American College of Medical Genetics and Genomics (ACMG) recently embarked on a systematic evidence review culminating in published recommendations for extensive changes in reproductive carrier screening testing. Genetics specialists across all disciplines have recognized the need for evidence-based guidelines promulgated by professional societies in this complex and challenging clinical space, as much of the …

ACMG Carrier Screening Recommendations: Points To Consider For An Effective and Equitable Carrier Screening Program Read More »

FAQ Videos: Genetic Test Payment Integrity for Health Plans

Inappropriate genetic testing spend is a big concern for health plans. Our expert genetic analysts understand this pain point and have some answers to commonly posed questions by health plans. Take a few minutes to watch our two-part video series in which one of our genetics claims analysts and board-certified genetic counselor, Katie Wiens, answers …

FAQ Videos: Genetic Test Payment Integrity for Health Plans Read More »

Solverwp- WordPress Theme and Plugin